BlackRock’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
38,156
+10,642
| +39% | +$28.4K | ﹤0.01% | 4763 |
|
|
2025
Q1 | $221K | Sell |
27,514
-3
| -0% | -$24 | ﹤0.01% | 4535 |
|
|
2024
Q4 | $266K | Hold |
27,517
| – | – | ﹤0.01% | 4510 |
|
|
2024
Q3 | $512K | Sell |
27,517
-49
| -0.2% | -$911 | ﹤0.01% | 4267 |
|
|
2024
Q2 | $459K | Sell |
27,566
-119,644
| -81% | -$1.99M | ﹤0.01% | 4317 |
|
|
2024
Q1 | $2.56M | Sell |
147,210
-6,099
| -4% | -$106K | ﹤0.01% | 3857 |
|
|
2023
Q4 | $2.4M | Sell |
153,309
-13,892
| -8% | -$217K | ﹤0.01% | 3896 |
|
|
2023
Q3 | $8.27M | Buy |
167,201
+22,664
| +16% | +$1.12M | ﹤0.01% | 3394 |
|
|
2023
Q2 | $11.3M | Buy |
144,537
+28,299
| +24% | +$2.21M | ﹤0.01% | 3295 |
|
|
2023
Q1 | $10.5M | Sell |
116,238
-6,231
| -5% | -$565K | ﹤0.01% | 3223 |
|
|
2022
Q4 | $14.5M | Buy |
122,469
+6,492
| +6% | +$766K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $21M | Buy |
115,977
+8,212
| +8% | +$1.49M | ﹤0.01% | 2958 |
|
|
2022
Q2 | $9.67M | Buy |
107,765
+10,769
| +11% | +$966K | ﹤0.01% | 3449 |
|
|
2022
Q1 | $15.1M | Buy |
96,996
+2,728
| +3% | +$424K | ﹤0.01% | 3278 |
|
|
2021
Q4 | $28.1M | Buy |
94,268
+15,434
| +20% | +$4.59M | ﹤0.01% | 3002 |
|
|
2021
Q3 | $45.4M | Buy |
78,834
+2,856
| +4% | +$1.65M | ﹤0.01% | 2692 |
|
|
2021
Q2 | $34.5M | Sell |
75,978
-27,199
| -26% | -$12.3M | ﹤0.01% | 2901 |
|
|
2021
Q1 | $55.5M | Buy |
103,177
+24,284
| +31% | +$13.1M | ﹤0.01% | 2510 |
|
|
2020
Q4 | $69.8M | Buy |
78,893
+27,955
| +55% | +$24.7M | ﹤0.01% | 2242 |
|
|
2020
Q3 | $32.2M | Buy |
+50,938
| New | +$32.2M | ﹤0.01% | 2505 |
|